Integrating smoking cessation treatment into IAPT care

  • Research type

    Research Study

  • Full title

    intEgrating Smoking Cessation treatment As part of routine Psychological care for dEpression (ESCAPE): a pragmatic randomised controlled, acceptability and feasibility trial

  • IRAS ID

    239339

  • Contact name

    Tom Freeman

  • Contact email

    T.P.Freeman@bath.ac.uk

  • Sponsor organisation

    The University of Bath

  • ISRCTN Number

    ISRCTN99531779

  • Clinicaltrials.gov Identifier

    17/WM/0251, REC

  • Duration of Study in the UK

    0 years, 11 months, 31 days

  • Research summary

    Tobacco is the world’s leading cause of disease and death. In the United Kingdom and in western nations smoking prevalence has declined significantly in the general population, but has not changed much in people with mental health disorders, resulting in high rates of smoking-related disease and death in this group. People with depression or anxiety are twice as likely to smoke, they are more heavily addicted to cigarettes, and are less responsive to usual tobacco treatments compared to people without depression/anxiety. Because of these inequalities there is a need for treatments that target both mental and physical health. In England, people with common mental health disorders have access to NHS therapy, known as ‘Improving Access to Psychological Therapies’ or IAPT, for short. IAPT may be an ideal platform for offering people with depression or anxiety smoking cessation treatment.

    In this study we will examine if it’s possible to treat tobacco addiction alongside usual IAPT treatment. Across two IAPT sites (Bristol Wellbeing Therapies, and TalkSpace Oxford) 157 IAPT clients who smoke will be recruited into the study and will be randomly allocated to receive either: a) smoking cessation treatment alongside their usual IAPT treatment, or b) usual IAPT treatment, plus a referral to their local stop smoking services at the end of the IAPT treatment. We will examine the following outcomes at 3-months after baseline: smoking intervention programme completion, attrition, mental health, smoking status, and other implementation, feasibility and acceptability measures.

  • REC name

    South West - Frenchay Research Ethics Committee

  • REC reference

    18/SW/0043

  • Date of REC Opinion

    5 Apr 2018

  • REC opinion

    Further Information Favourable Opinion